Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- University of Basel
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- Amsterdam UMC
- CHINESE UNIVERSITY OF HONG KONG
- FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA
- Faculty of Science, Charles University
- Heidelberg University
- Institute of Mathematics and Informatics
- Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB)
- Karolinska Institutet, doctoral positions
- NTNU Norwegian University of Science and Technology
- Princess Máxima Center for Pediatric Oncology
- Purdue University
- The Belgian Nuclear Research Centre
- University of Nottingham
- Vrije Universiteit Brussel (VUB)
- 6 more »
- « less
-
Field
-
) on mathematical modelling of immunotherapies of hematologic malignancies is available at the Institute of Mathematics and Informatics in Sofia, Bulgaria under the supervision of Dr. Peter Rashkov, Dept
-
en Farmacologische Wetenschappen, Research Group Neuro-Aging & Viro-Immunotherapy (NAVI) is looking for a PhD-student with a doctoral grant. Are you fascinated by innate immunity and its role in viral
-
cancer. Research in the Binder group addresses translational aspects in immuno-oncology, with a strong focus on improving immunotherapy and develop novel targeted antibody-based and cellular treatment
-
in the Binder group addresses translational aspects in immuno-oncology, with a strong focus on improving immunotherapy and develop novel targeted antibody-based and cellular treatment approaches
-
group addresses translational aspects in immuno-oncology, with a strong focus on improving immunotherapy and develop novel targeted antibody-based and cellular treatment approaches for hematological and
-
Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB) | Spain | about 1 month ago
to apply Website https://rrhh.ffis.es/rrhh/ofertaEmpleo.jsf?id=1946 Requirements Research FieldOtherEducation LevelPhD or equivalent Skills/Qualifications Development of somatic cell therapy: Preclinical
-
to develop better immunotherapy approaches. You will be working in a stimulating, multi-disciplinary research environment with international collaborations. Are you willing to take on the challenge
-
intensive research, effective therapies remain scarce and the prognosis for this patient group is poor. Although immunotherapy is promising for various types of cancer, patients with peritoneal metastases
-
immunotherapy have been introduced in the treatment schemes of GC, but their positive impact in patient survival is still modest. Thus, identification of molecular mechanisms that may have a more significant
-
a proven commitment to advancing research in immunotherapies. The appointee is expected to (a) work closely with Prof. XIA Jiang’s research group (https://chem.cuhk.edu.hk/people/academic-staff/xj